RE:RE:RE:RE:RE:RE:RE:HEXO CORPDon't know where you got those numbers. Here's what I found...
Constellation | Brands | | |
PS | Shares (M) | MC (M) | Sales (M) |
216.97 | 168.20 | 36,494.35 | 9,355.70 |
| | | |
Factor (x sales) | 43.12 | | |
EBITDA (M) | 3,222.40 | | |
The big difference is in the last line. You have a company in Constellation Brands free of debt, Hexo isn't in that category.
LINK: https://money.tmx.com/en/quote/STZ:US/financials-filings
Touran77 wrote:
Let's take Constellations.
Similar sector, similar vice :p.
1.25B a quarter, resulting in 5B a year of sales.
Market cap of 40B or 8 times yearly sales.
Even if I am conservative and say 25M Hexo, 25 Redecan, 10 Zena and 3 48N a quarter, this is 63M a quarter resulting in 252M a year.
252 times 8 (PS ratio from constellation) is around 2B.
Hexo with 270M shares (post Redecan acquisition and last dilution) at 3 CAD is 810M in market cap.
What I am seeing here is that even if sector correct to be similar as other sectors (alcohol in this case), Hexo would not decrease. Yes Canopy and Tilray might, but where is the risk in owning Hexo when looking at this calculation?
This calculation is super conservative, no increase in Canada or anywhere.
If I'm missing anything, please share my friend.
Tonto